Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 6;15(1):8.
doi: 10.1186/s13041-021-00892-6.

Progress on the roles of MEF2C in neuropsychiatric diseases

Affiliations
Review

Progress on the roles of MEF2C in neuropsychiatric diseases

Zhikun Zhang et al. Mol Brain. .

Abstract

Myocyte Enhancer Factor 2 C (MEF2C), one of the transcription factors of the MADS-BOX family, is involved in embryonic brain development, neuronal formation and differentiation, as well as in the growth and pruning of axons and dendrites. MEF2C is also involved in the development of various neuropsychiatric disorders, such as autism spectrum disorders (ASD), epilepsy, schizophrenia and Alzheimer's disease (AD). Here, we review the relationship between MEF2C and neuropsychiatric disorders, and provide further insights into the mechanism of these diseases.

Keywords: MEF2C; Neurodevelopment; Neuropsychiatric disease; Synapse; Transcription factor.

PubMed Disclaimer

Conflict of interest statement

Both authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The functional regulation model of MEF2C in neuronal cells, where MEF2C is particularly important for the regulation of dendritic spines. The blue italics are MEF2C-associated psychoneurotic disorders

Similar articles

Cited by

References

    1. Adachi M, Lin PY, Pranav H, Monteggia LM. Postnatal loss of Mef2c results in dissociation of effects on synapse number and learning and memory. Biol Psychiatry. 2016;80(2):140–148. doi: 10.1016/j.biopsych.2015.09.018. - DOI - PMC - PubMed
    1. Akhtar MW, Kim MS, Adachi M, Morris MJ, Qi X, Richardson JA, et al. In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS ONE. 2012;7(4):e34863. doi: 10.1371/journal.pone.0034863. - DOI - PMC - PubMed
    1. Angelelli C, Magli A, Ferrari D, Ganassi M, Matafora V, Parise F, et al. Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells. Nucleic Acids Res. 2008;36(3):915–928. doi: 10.1093/nar/gkm1114. - DOI - PMC - PubMed
    1. Assali A, Harrington AJ, Cowan CW. Emerging roles for MEF2 in brain development and mental disorders. Curr Opin Neurobiol. 2019;59:49–58. doi: 10.1016/j.conb.2019.04.008. - DOI - PMC - PubMed
    1. Bai XL, Zhang Q, Ye LY, Liang F, Sun X, Chen Y, et al. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/beta-catenin signaling. Oncogene. 2015;34(31):4089–4097. doi: 10.1038/onc.2014.337. - DOI - PubMed

Substances